FindTrial
Sign In

LY03017-Placebo

DRUG2 trials

Sponsors

Luye Pharma Group Ltd.

Conditions

Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia

Phase 1

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017
Not yet recruitingNCT06388551
Luye Pharma Group Ltd.Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia
Start: 2024-05-10End: 2025-03-30Target: 60Updated: 2024-04-29
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
Not yet recruitingNCT06980207
Luye Pharma Group Ltd.Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis, Negative Symptoms of Schizophrenia
Start: 2025-05-31End: 2025-10-31Target: 40Updated: 2025-05-20